Načítá se...
What is the future of targeted therapy in rheumatology: biologics or small molecules?
BACKGROUND: Until late in the 20th century, the therapy of rheumatic diseases relied on the use of drugs that had been developed through empirical approaches without detailed understanding of the molecular mechanisms involved. That approach changed with the introduction of biologic therapeutics at t...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3975154/ https://ncbi.nlm.nih.gov/pubmed/24620738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-12-43 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|